News
(Reuters) -Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer ...
(Reuters) -Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease ...
Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...
Breakthrough as two FDA-approved drugs are found to reverse Alzheimer’s — including restoring memory
Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice.
Amityville’s new Barbara Rabinowitz Education & Resource Center includes even a special transit-focused room to teach ...
Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% ...
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
Scientists at UCSF have uncovered how certain immune cells in the brain, called microglia, can effectively digest toxic ...
Dear Abby gives advice to a reader whose friend has been rude since being diagnosed with early Alzheimer’s disease.
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results